Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
MAIT cells in autoimmunity.
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Multiple sclerosis: summary of NICE guidance.
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Towards establishing MS prevalence in Latin America and the Caribbean.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Pediatric multiple sclerosis in Venezuela.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
JC viremia in natalizumab-treated patients with multiple sclerosis.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
Prolongation of survival of rat cardiac allografts by T cell vaccination.
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Is multiple sclerosis an autoimmune disease?
Enrollment complete for cannabinoid MS study
Simvastatin: a review.
The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Psychiatric disorders in neurology.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
Pages
« first
‹ previous
…
184
185
186
187
188
189
190
191
192
…
next ›
last »